XML 15 R4.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 26, 2020
Sep. 28, 2019
Sep. 26, 2020
Sep. 28, 2019
Revenues:        
Total revenues $ 9,512,752 $ 6,139,332 $ 26,206,003 $ 20,792,390
Expenses:        
Cost of product revenues 4,825,032 4,689,944 15,252,456 15,809,535
Research and development 2,715,868 2,389,573 7,276,770 10,686,491
Selling, general and administration 3,079,567 5,130,019 9,421,024 16,788,493
Impairment of goodwill 331,344 331,344
Total expenses 10,620,467 12,540,880 31,950,250 43,615,863
Loss from operations (1,107,715) (6,401,548) (5,744,247) (22,823,473)
Other income (expense):        
Interest income 12,751 120,645 120,187 438,316
Other expense, net (28,600) (109,614) (65,680) (330,821)
Foreign currency transaction gains (losses) 183,795 (88,847) 20,797 (36,320)
Gain on investments 768,000
Total other income and expense 167,946 (77,816) 75,304 839,175
Loss before provision for income taxes and net loss (income) attributable to noncontrolling interest (939,769) (6,479,364) (5,668,943) (21,984,298)
Tax provision (29,000) (26,000) (100,000) (78,000)
Net loss (968,769) (6,505,364) (5,768,943) (22,062,298)
Net loss (income) attributable to the noncontrolling interest 11,329 (120,094) 94,443 (154,478)
Net loss attributable to Kopin Corporation $ (957,440) $ (6,625,458) $ (5,674,500) $ (22,216,776)
Net loss per share        
Basic and diluted $ (0.01) $ (0.08) $ (0.07) $ (0.28)
Weighted average number of common shares outstanding        
Basic and diluted 82,596,416 82,053,698 82,567,401 79,657,677
Net Product Revenues [Member]        
Revenues:        
Total revenues $ 6,487,581 $ 4,955,062 $ 19,077,090 $ 14,004,319
Research and Development and Other Revenues [Member]        
Revenues:        
Total revenues $ 3,025,171 $ 1,184,270 $ 7,128,913 $ 6,788,071